[Webinar] How to better optimize an oncology drug discovery program
Register for this webinar discussing how conventional and innovative integrated technological skills should be incorporated into an oncology program.
Read more After the discovery and proof-of-concept phases, the preclinical development of new therapeutic entities is a critical step for the regulatory approval of the first-in-man administration and the transition to the early phases of clinical trials.
D-VLOP, a network of expert partners all renowned and experienced in preclinical and clinical development, is the solution to successfully complete this phase.
Together with our partners Cynbiose, ERBC and PharmaLexwe bring you advice and support to define and implement your pre-clinical and clinical strategic program in line with your requirements and those of the regulatory authorities.
D-VLOP addresses all the needs of start-ups, small and medium biotechnology companies that need expertise in the preclinical and clinical phases of drug development, but also large pharmaceutical companies with specialized development needs.